Latest News & Updates
Breaking News
14 hours ago
Simantini Singh Deo
Other trending news you may like to read
FDA Issues Complete Response Letter For Pharming’s Joenja® sNDA In Children 4–11 With Rare APDS, Citing Pediatric Dose And Batch Testing Data Needs
FDA issues CRL for Joenja in children 4–11 with APDS, requesting additional PK and testing data. Approval for ages 12+ unchanged.
Simantini Singh Deo
NurExone Appoints Eyal Gabbai To Board As It Prepares For Clinical Milestones
NurExone Biologic adds healthcare and finance leader Eyal Gabbai to its board as it prepares for clinical and market milestones.
Vaibhavi M.
Palisade Bio Adds Global IBD Leaders Laurent Peyrin-Biroulet And David T. Rubin To Clinical Advisory Board As Company Prepares PALI-2108 For Development
Palisade Bio appoints two leading IBD specialists to its Clinical Advisory Board to support PALI-2108 development.
Simantini Singh Deo
Elevar Therapeutics Appoints Dong-Gun Kim As New CEO To Lead Company’s Post-NDA Commercialization Strategy
Elevar Therapeutics appoints Dong-Gun Kim as CEO following NDA submissions for liver and bile duct cancer therapies.
Simantini Singh Deo
